Cardiff University School of Medicine, UK.
Anticancer Agents Med Chem. 2010 Jan;10(1):64-9. doi: 10.2174/1871520611009010064.
Matriptase-2 is a newly identified member of the Type II Transmembrane Serine Protease (TTSP) family. The expression profile of many members of this family of proteases is frequently altered in cancerous cells and tissues and a number of TTSPs have been linked to cancer progression and development. Matriptase-2 is structurally similar to matriptase-1, a TTSP which has gained recent interest due to its potential to enhance the aggressive nature of cancer cells and its links with a variety of human cancers. Recently, matriptase-2 has been functionally linked to the regulation of iron metabolism; however, there is also evidence to suggest that, as with other members of the TTSPs, matriptase-2 may have a role in cancer development and progression. This article reviews the current literature on matriptase-2, together with its potential roles in physiological and disease states particularly focusing on cancer.
组织蛋白酶 2 是一种新鉴定的 II 型跨膜丝氨酸蛋白酶(TTSP)家族成员。这个蛋白酶家族的许多成员的表达谱在癌细胞和组织中经常发生改变,并且一些 TTSP 与癌症的进展和发展有关。组织蛋白酶 2 在结构上与组织蛋白酶 1 相似,组织蛋白酶 1 是一种 TTSP,由于其增强癌细胞侵袭性的潜力及其与多种人类癌症的联系,最近引起了人们的关注。最近,组织蛋白酶 2 的功能与铁代谢的调节有关;然而,也有证据表明,与 TTSP 的其他成员一样,组织蛋白酶 2 可能在癌症的发展和进展中发挥作用。本文综述了目前关于组织蛋白酶 2 的文献,以及它在生理和疾病状态下的潜在作用,特别是在癌症方面。